Senior insider sale
VIKING THERAPEUTICS, INC. — senior position signals high conviction
$4.58M
68.79K shares
What this filing means
SINGLETON J MATTHEW plans to sell 68.79K shares of VIKING THERAPEUTICS, INC. valued at approximately $4.58M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/25/2024ACC: 0000103623-24-000081
Director
Since Jan 2019
68.79K
Shares to sell
$4.58M
Approx. market value
16K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
NQSO
N/A
1/2/2018
16KTotal acquired16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2018 | NQSO N/A | 16K | — |
| Total | 16K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
10.30K
Market value
$715.9K
9/20/2024
—Completed
Units to sell
5.70K
Market value
$397.4K
8/21/2024
—Completed
Units to sell
16K
Market value
$995.4K
8/19/2024
—Completed
Units to sell
20.79K
Market value
$1.20M
8/14/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
16K
Market value
$1.27M
10/25/2024
Total
Units
68.79K
Value
$4.58M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/20/2024 | 10.30K | $715.9K | — | Completed |
8/21/2024 | 5.70K | $397.4K | — | Completed |
8/19/2024 | 16K | $995.4K | — | Completed |
8/14/2024 | 20.79K | $1.20M | — | Completed |
| Planned — Approximate Date | ||||
10/25/2024 | 16K | $1.27M | NASDAQ | Planned |
| Total | 68.79K | $4.58M | ||